Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/EBIT(x) 26.4737.5438.9425.3832.89

What is the latest EV/EBIT ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 26.47 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar202626.47
Mar202537.54
Mar202438.94
Mar202325.38
Mar202232.89

How is EV/EBIT of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2026 26.47
-29.49
Mar2025 37.54
-3.60
Mar2024 38.94
53.43
Mar2023 25.38
-22.83
Mar2022 32.89 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹46,185.2 Cr 9% 7.7% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

9%

7.7%

4.2%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses